# US Thyroid Test Market > US Thyroid Test Market Research Report By Type (TSH Tests, T4 Tests, T3 Tests, Other) and By End User (Hospital, Diagnostic Laboratories, Research Laboratories and Institutes) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.69% - **2024:** $ 432.55 Million - **2025:** $ 457.16 Million - **2035:** $ 795.23 Million - **Key Players:** Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Siemens Healthineers (DE), PerkinElmer (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Quest Diagnostics (US) **Report ID:** MRFR/HC/18000-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-thyroid-test-market-19547 --- ## Market Summary ## **US Thyroid Test Market Overview** As per MRFR analysis, the US Thyroid Test Market Size was estimated at 410.19 (USD Million) in 2023. The US Thyroid Test Market Industry is expected to grow from 433.65(USD Million) in 2024 to 979.13 (USD Million) by 2035. The US Thyroid Test Market CAGR (growth rate) is expected to be around 7.685% during the forecast period (2025 - 2035). ### **Key US Thyroid Test Market Trends Highlighted** The US Thyroid Test Market is experiencing notable trends that reflect the increasing awareness and demand for thyroid health assessments. A key market driver includes the rising prevalence of thyroid disorders, commonly diagnosed through laboratory tests and often requiring ongoing monitoring. The American Thyroid Association reports that millions of Americans are affected by conditions such as hypothyroidism and hyperthyroidism, driving the need for efficient testing solutions. There are also significant opportunities to be explored in telemedicine and home testing kits. With the ongoing digital transformation in healthcare, patients are increasingly seeking convenient testing options that can be conducted from the comfort of their homes. This trend is fueled by advancements in technology and a growing consumer preference for personalized healthcare solutions. Recently, there has been a surge in the development of more sensitive and specific testing methods, enhancing the accuracy of thyroid function assessments. The introduction of innovative biomarkers and automated testing systems is streamlining processes and reducing the turnaround time for test results. Additionally, educational initiatives by healthcare organizations are further promoting awareness about thyroid health and the importance of regular screening, contributing to higher testing rates. These trends highlight a dynamic landscape in the US Thyroid Test Market, driven by both consumer demands and technological advancements, positioning stakeholders for substantial growth and engagement in the coming years. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **US Thyroid Test Market Drivers** #### **Increasing Prevalence of Thyroid Disorders** The increasing prevalence of thyroid disorders in the United States is a significant driver for the US [Thyroid Test Market](../../../reports/thyroid-test-market-8548) Industry. According to the American Thyroid Association, it is estimated that approximately 20 million Americans have some form of thyroid disease, with 60% of those unaware of their condition. The rising awareness and diagnosis of these disorders will drive demand for thyroid testing. Additionally, the Centers for Disease Control and Prevention has reported that thyroid function tests, such as thyroid stimulating hormone (TSH) tests, represent a crucial aspect of healthcare for individuals over 35 years old, highlighting the need for comprehensive screening programs. Such statistics indicate a growing market where proactive healthcare measures are being implemented, subsequently increasing the market for thyroid tests in the U.S. #### **Technological Advancements in Diagnostic Techniques** Advancements in technology related to diagnostic tools have significantly impacted the US Thyroid Test Market Industry. Recent innovations in high-throughput screening methods and the development of more sensitive assays for thyroid hormones enable quicker and more accurate diagnosis. According to the U.S. Food and Drug Administration, the approval of innovative diagnostic devices has facilitated an increase in the number of tests being performed in the U.S., with a reported annual growth rate of about 6% in the adoption of advanced testing technologies. This technological evolution is not only enhancing diagnostic accuracy but also expanding the range of available tests, which contributes positively to the market growth. #### **Rising Awareness of Preventive Healthcare** There is a growing trend towards preventive healthcare in the United States, which is notably influencing the US Thyroid Test Market Industry. Educational campaigns and programs aimed at raising public awareness about thyroid health are becoming more common. The U.S. Department of Health and Human Services has emphasized the importance of preventive services, including regular thyroid screenings, especially among high-risk populations. This shift in focus towards prevention is reflected in studies showing that about 50% of patients diagnosed with thyroid conditions had undergone testing following awareness campaigns. The increased public demand for such preventative measures can significantly bolster the market for thyroid testing services. ## **US Thyroid Test Market Segment Insights** ### **Thyroid Test Market Type Insights** The US Thyroid Test Market is characterized by its diverse Type segmentation, which includes categories such as TSH Tests, T4 Tests, T3 Tests, and Other tests. Each of these segments plays a vital role in diagnosing and managing thyroid conditions, which have become increasingly prevalent in the United States. With a growing awareness of thyroid disorders among the population, the demand for these tests is witnessing significant growth. Among these, TSH (Thyroid Stimulating Hormone) tests are particularly notable due to their widespread use as the initial screening tool for thyroid dysfunctions. They help assess the pituitary gland's role in regulating thyroid hormone production, making them crucial in both diagnosing hypothyroidism and hyperthyroidism. The T4 tests, which measure the levels of Thyroxine in the bloodstream, are also critical as they provide insights into the thyroid's overall function and hormone output. Given that T4 is a key hormone produced by the thyroid gland, these tests often complement TSH tests, allowing healthcare providers to form a comprehensive overview of thyroid health. In contrast, T3 tests measure the Triiodothyronine hormone levels, and while they are less commonly ordered than TSH and T4 tests, they are essential for certain cases, particularly in evaluating hyperthyroidism. The Other segment typically includes various specialized tests and procedures that may need to be conducted for more complex cases or rare conditions affecting the thyroid. As healthcare organizations in the United States continue to emphasize preventive care and early diagnosis, the importance of thyroid tests is increasingly recognized. Factors driving the growth of the US Thyroid Test Market include an aging population, heightened incidence of thyroid diseases, and advancements in laboratory technology. With more accurate and efficient testing methods emerging, healthcare providers are equipped to make better-informed decisions, which in turn enhances patient outcomes. Furthermore, the rise in health awareness campaigns and improved access to healthcare facilities are contributing to increased testing rates across all segments, thereby positively impacting the overall US Thyroid Test Market revenue. Such dynamics underscore the importance of understanding the market segmentation, as each segment plays a significant role in addressing the thyroid health needs of the population. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Thyroid Test Market End User Insights** In the US Thyroid Test Market, the End User segment plays a crucial role in determining the overall demand and application of thyroid testing. The market is primarily divided among Hospitals, Diagnostic Laboratories, and Research Laboratories and Institutes, each serving different functions and needs. Hospitals are essential in providing immediate and comprehensive healthcare services, often being the first point of contact for patients requiring thyroid evaluations. Diagnostic Laboratories are significant as they handle a substantial volume of tests, ensuring accuracy and reliability in results, which is essential for patient diagnosis and treatment decisions. Research Laboratories and Institutes contribute to the advancement of thyroid research, enabling the development of new and innovative testing methods, thereby driving the overall market growth. The increasing prevalence of thyroid disorders and advancements in healthcare technology are key growth drivers within this segment. Moreover, rising awareness about thyroid health and the availability of advanced diagnostic solutions further solidify the market's potential. The emphasis on accurate diagnostics in these various End User categories underscores their importance in the healthcare ecosystem, ultimately ensuring that the growing demand for thyroid testing is met effectively. ## **US Thyroid Test Market Key Players and Competitive Insights** The US Thyroid Test Market has seen significant growth driven by increasing awareness of thyroid-related disorders and advancements in diagnostic technologies. This market is characterized by a diverse range of players offering various testing solutions, including blood tests, imaging studies, and genetic assessments. As the prevalence of thyroid diseases such as hypothyroidism and hyperthyroidism continues to rise, the demand for timely and accurate testing has become paramount. The competitive landscape is shaped by several factors including innovation in testing methodologies, regulatory advancements, partnerships, and mergers and acquisitions that enhance service delivery and expand market reach. Companies in this sector are actively engaging in research and development to refine existing tests and create new ones that can provide faster and more accurate results for healthcare providers and patients. Laboratory Corporation of America Holdings has emerged as a frontrunner in the US Thyroid Test Market, leveraging its extensive laboratory network and state-of-the-art technology to deliver comprehensive testing solutions. The company has built a robust presence by focusing on providing high-quality services that physicians and patients can rely on for accurate thyroid diagnostics. Their strengths include a wide-ranging test menu, quick turnaround times, and a commitment to leveraging cutting-edge technology in laboratory processes. Laboratory Corporation of America Holdings has established numerous partnerships and collaborations with healthcare providers and institutions, enabling them to broaden their testing capabilities and reinforce their market share. Their proficiency in automating laboratory processes allows for enhanced efficiency and reliability, making them a preferred choice among healthcare professionals. BioRad Laboratories holds a significant position in the US Thyroid Test Market, known for its innovative products and commitment to advancing diagnostic solutions. The company offers an array of key products and services tailored to thyroid testing, which include high-quality assays and reagents that help in the precise diagnosis of thyroid dysfunctions. BioRad's strengths lie in its advanced research and development capabilities, which facilitate the continuous improvement of its testing offerings. The company's strategic intent often involves merging or acquiring smaller firms or technologies to bolster its portfolio, thereby enhancing its competitive edge in the market. BioRad has successfully maintained a significant market presence thanks to its dedication to quality, reliability, and innovation, which resonate well with customer needs in the US healthcare landscape. By constantly evolving its approach to service delivery and product development, BioRad Laboratories stands as a strong competitor in the thyroid testing segment within the United States. ### **Key Companies in the US Thyroid Test Market Include** ### **US Thyroid Test Market Industry Developments** The US Thyroid Test Market has seen significant developments, particularly with advancements in testing technologies and increased emphasis on early diagnosis of thyroid disorders. In September 2023, Laboratory Corporation of America Holdings expanded its test offerings to include advanced thyroid function tests, reflecting growing consumer demand for comprehensive health screenings. Abbott Laboratories has also made strides by launching an innovative point-of-care test aimed at improving the speed of diagnosis for thyroid disorders. On the acquisition front, in August 2023, Thermo Fisher Scientific announced its acquisition of a diagnostics company focused on specialized thyroid testing, enhancing its product portfolio. Additionally, Quest Diagnostics reported a notable increase in service demand, driving growth in market valuations. Over the past two to three years, companies like F. Hoffmann-La Roche AG and Siemens Healthineers have invested heavily in Research and Development to launch next-generation assays that improve accuracy in thyroid testing. The surge in thyroid conditions and the growing awareness among healthcare providers and patients are anticipated to propel market growth further, complemented by technological enhancements and the introduction of innovative testing solutions. ## **US Thyroid Test Market Segmentation Insights** ### **Thyroid Test Market Type Outlook** ### **Thyroid Test Market End User Outlook** ## Market Drivers ### Rising Incidence of Thyroid Disorders The thyroid test market is experiencing growth due to the increasing prevalence of thyroid disorders in the US. Conditions such as hypothyroidism and hyperthyroidism are becoming more common, with estimates suggesting that approximately 20 million Americans have some form of thyroid disease. This rising incidence drives demand for accurate and timely testing, as early diagnosis is crucial for effective management. The thyroid test market is likely to benefit from this trend, as healthcare providers seek reliable testing solutions to address the growing patient population. Furthermore, the aging population, which is more susceptible to thyroid issues, contributes to the market's expansion. As awareness of thyroid health increases, the need for comprehensive testing options becomes more pronounced, indicating a robust future for the thyroid test market. ### Growing Focus on Preventive Healthcare The thyroid test market is benefiting from a broader trend towards preventive healthcare in the US. Patients and healthcare providers are increasingly recognizing the importance of early detection and management of thyroid disorders. This shift is reflected in the rising number of routine screenings and check-ups that include thyroid function tests. The thyroid test market is likely to see a surge in demand as more individuals seek proactive health measures. Additionally, public health campaigns aimed at educating the population about thyroid health are contributing to this trend. As awareness grows, the market may experience a significant increase in testing frequency, further solidifying its role in preventive healthcare strategies. ### Advancements in Diagnostic Technologies Technological innovations are significantly impacting the thyroid test market. The introduction of advanced diagnostic tools, such as high-sensitivity assays and point-of-care testing devices, enhances the accuracy and speed of thyroid function assessments. These advancements allow for more precise measurement of thyroid hormones, which is essential for effective diagnosis and treatment. The thyroid test market is likely to see increased adoption of these technologies, as healthcare providers aim to improve patient outcomes. Moreover, the integration of artificial intelligence in diagnostic processes may streamline testing procedures, potentially reducing costs and increasing efficiency. As a result, the thyroid test market is positioned for growth, driven by the demand for cutting-edge diagnostic solutions. ### Increased Access to Healthcare Services Access to healthcare services is improving across the US, which is positively influencing the thyroid test market. With the expansion of insurance coverage and the establishment of community health programs, more individuals are able to obtain necessary testing. This increased access is particularly beneficial for underserved populations who may have previously faced barriers to healthcare. The thyroid test market is likely to see growth as more people seek testing services, driven by the availability of affordable healthcare options. Furthermore, telehealth services are becoming more prevalent, allowing patients to consult with healthcare providers remotely and receive testing referrals. This trend may further enhance the market's reach and accessibility. ### Regulatory Support for Diagnostic Innovations The thyroid test market is experiencing favorable conditions due to regulatory support for diagnostic innovations. The US Food and Drug Administration (FDA) has been actively approving new testing methods and devices that enhance the accuracy and efficiency of thyroid assessments. This regulatory environment encourages research and development within the thyroid test market, fostering innovation and competition. As new products enter the market, healthcare providers gain access to a wider array of testing options, which may improve patient care. Additionally, streamlined approval processes for novel diagnostic tools could accelerate the introduction of advanced technologies, further propelling the growth of the thyroid test market. ## Future Outlook The [Thyroid Test Market](https://www.marketresearchfuture.com/reports/thyroid-test-market-8548) is projected to grow at a 5.69% CAGR from 2025 to 2035, driven by increasing prevalence of thyroid disorders and advancements in diagnostic technologies. **New opportunities:** - Development of point-of-care testing devices for rapid diagnosis - Expansion of telehealth services for remote thyroid monitoring - Investment in AI-driven analytics for personalized treatment plans By 2035, the thyroid test market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: TSH Tests (Largest) vs. T4 Tests (Fastest-Growing) The US thyroid test market shows a varied distribution of market share among its different test types. TSH tests dominate this segment, accounting for the largest share due to their widespread use and acceptance as the standard for assessing thyroid function. In contrast, T4 tests and T3 tests hold smaller portions of the market but play critical roles in the comprehensive assessment of thyroid health. Other tests comprise a niche segment catering to specific patient needs and conditions. In terms of growth trends, T4 tests are emerging as the fastest-growing segment within the US thyroid test market. This growth is driven by increasing awareness of thyroid disorders and the importance of monitoring hormone levels for treatment effectiveness. Additionally, advancements in testing technologies are making T4 tests more accessible, thereby expanding their adoption among healthcare providers and patients alike. TSH Tests (Dominant) vs. T4 Tests (Emerging) TSH tests are considered the dominant player in the US thyroid test market, largely due to their established role in diagnosing and managing thyroid function disorders. These tests are trusted for their reliability, leading to a high volume of annual tests performed across healthcare settings. On the other hand, T4 tests are emerging as a vital component in the evaluation of thyroid conditions, especially in situations where more detailed hormone analysis is necessary. As awareness of thyroid health grows, T4 tests are gaining popularity. Their ability to provide specific hormonal insights allows healthcare providers to tailor treatment plans effectively. This trend indicates increased demand for T4 testing in conjunction with traditional TSH assessments. ### By End-User: Hospital (Largest) vs. Diagnostic Laboratories (Fastest-Growing) In the US thyroid test market, hospitals currently hold the largest share due to their comprehensive range of healthcare services and the presence of advanced diagnostic technologies. This segment benefits from high patient volumes, leading to substantial test demands, which solidifies its leading market position. Conversely, diagnostic laboratories are emerging as the fastest-growing segment driven by the increasing prevalence of thyroid disorders and the rise in preventive healthcare practices. These facilities are adopting innovative testing methods and technologies to meet the growing demand, showcasing their capacity for rapid expansion in the market. Hospital (Dominant) vs. Diagnostic Laboratories (Emerging) Hospitals dominate the US thyroid test market as they provide a wide array of medical services, including advanced thyroid testing capabilities. Their established infrastructure and access to a large patient base ensure continuous testing and diagnosis, supporting their dominant status. Meanwhile, diagnostic laboratories represent an emerging segment characterized by their focus on specialized testing and quicker turnaround times. They are increasingly integrating automation and advanced testing technologies, enabling them to adapt swiftly to market demands and improving their competitive edge in the growing landscape of thyroid testing. ## Competitive Benchmarking The thyroid test market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on digital transformation. Key players such as Abbott Laboratories (US), Roche Diagnostics (CH), and Thermo Fisher Scientific (US) are at the forefront, leveraging their technological capabilities to enhance diagnostic accuracy and patient outcomes. Abbott Laboratories (US) has positioned itself as a leader in point-of-care testing, emphasizing rapid and reliable results, which is crucial in managing thyroid disorders. Meanwhile, Roche Diagnostics (CH) continues to invest heavily in research and development, aiming to expand its portfolio of thyroid testing solutions, thereby reinforcing its market presence. Thermo Fisher Scientific (US) appears to be focusing on integrating advanced analytics and AI into its testing platforms, which may enhance operational efficiency and diagnostic precision.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive dynamic fosters an environment where innovation is paramount, as companies strive to differentiate their offerings in a crowded marketplace. In October Abbott Laboratories (US) announced a strategic partnership with a leading telehealth provider to enhance remote thyroid testing capabilities. This collaboration is likely to expand access to testing services, particularly in underserved areas, thereby aligning with the growing trend towards telemedicine. Such initiatives not only broaden market reach but also cater to the evolving needs of patients seeking convenient healthcare solutions. In September Roche Diagnostics (CH) launched a new line of automated thyroid testing systems designed to improve laboratory efficiency and reduce turnaround times. This development underscores Roche's commitment to innovation and its strategic focus on enhancing laboratory workflows, which could potentially lead to increased adoption of its testing solutions among healthcare providers. In August Thermo Fisher Scientific (US) unveiled a new AI-driven analytics platform aimed at optimizing thyroid test interpretation. This move is indicative of the company's strategy to integrate cutting-edge technology into its offerings, which may enhance diagnostic accuracy and support clinicians in making informed decisions. The incorporation of AI into testing processes could represent a significant shift in how thyroid disorders are diagnosed and managed. As of November the competitive trends within the thyroid test market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, it is anticipated that competitive differentiation will evolve, with a shift from traditional price-based competition towards a focus on technological advancements, innovative solutions, and reliable supply chains. This transition may ultimately redefine the landscape of the thyroid test market, emphasizing the importance of quality and efficiency in meeting the needs of healthcare providers and patients alike. ## Recent News & Developments The US Thyroid Test Market has seen significant developments, particularly with advancements in testing technologies and increased emphasis on early diagnosis of thyroid disorders. In September 2023, Laboratory Corporation of America Holdings expanded its test offerings to include advanced thyroid function tests, reflecting growing consumer demand for comprehensive health screenings. Abbott Laboratories has also made strides by launching an innovative point-of-care test aimed at improving the speed of diagnosis for thyroid disorders. On the acquisition front, in August 2023, Thermo Fisher Scientific announced its acquisition of a diagnostics company focused on specialized thyroid testing, enhancing its product portfolio. Additionally, Quest Diagnostics reported a notable increase in service demand, driving growth in market valuations. Over the past two to three years, companies like F. Hoffmann-La Roche AG and Siemens Healthineers have invested heavily in Research and Development to launch next-generation assays that improve accuracy in thyroid testing. The surge in thyroid conditions and the growing awareness among healthcare providers and patients are anticipated to propel market growth further, complemented by technological enhancements and the introduction of innovative testing solutions. ## Report Scope | MARKET SIZE 2024 | 432.55(USD Million) | | --- | --- | | MARKET SIZE 2025 | 457.16(USD Million) | | MARKET SIZE 2035 | 795.23(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.69% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Siemens Healthineers (DE), PerkinElmer (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Quest Diagnostics (US) | | Segments Covered | Type, End-User | | Key Market Opportunities | Integration of advanced diagnostic technologies enhances accuracy in the thyroid test market. | | Key Market Dynamics | Rising consumer awareness drives demand for thyroid testing, influencing market growth and competitive strategies. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall market valuation of the US thyroid test market in 2024?** A: The overall market valuation was 432.55 USD Million in 2024. **Q: What is the projected market valuation for the US thyroid test market by 2035?** A: The projected valuation for 2035 is 795.23 USD Million. **Q: What is the expected CAGR for the US thyroid test market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 5.69%. **Q: Which companies are considered key players in the US thyroid test market?** A: Key players include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, PerkinElmer, Bio-Rad Laboratories, Ortho Clinical Diagnostics, and Quest Diagnostics. **Q: What were the revenue figures for TSH tests in the US thyroid test market in 2024?** A: Revenue for TSH tests ranged from 150.0 to 280.0 USD Million in 2024. **Q: How did the revenue for T4 tests compare to T3 tests in 2024?** A: T4 tests generated revenue between 120.0 and 220.0 USD Million, whereas T3 tests ranged from 80.0 to 150.0 USD Million. **Q: What was the revenue range for diagnostic laboratories as an end-user segment in 2024?** A: Diagnostic laboratories accounted for revenue between 180.0 and 350.0 USD Million in 2024. **Q: What is the revenue range for research laboratories and institutes in the US thyroid test market?** A: Research laboratories and institutes generated revenue between 102.55 and 165.23 USD Million in 2024. **Q: What are the projected revenue figures for the 'Other' segment in the US thyroid test market?** A: The 'Other' segment is projected to generate revenue between 82.55 and 145.23 USD Million. **Q: How does the US thyroid test market's growth outlook appear for the next decade?** A: The market's growth outlook appears positive, with a projected valuation increase to 795.23 USD Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-thyroid-test-market-19547*